Non-coding RNA in cancer drug resistance: Underlying mechanisms and clinical applications

Non-coding RNA in cancer drug resistance: Underlying mechanisms and clinical applications

Cancer is one of the most frequently diagnosed malignant diseases worldwide, posing a serious, long-term threat to patients’ health and life. Systemic chemotherapy remains the first-line therapeutic approach for recurrent or metastatic cancer patients after surgery, with the potential to effectively...

Full description

Bibliographic Details
Main Authors: Xuehao Zhou, Xiang Ao, Zhaojun Jia, Yiwen Li, Shouxiang Kuang, Chengcheng Du, Jinyu Zhang, Jianxun Wang, Ying Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Oncology
Subjects:
non-coding RNA
cancer
drug resistance
biomarker
therapeutic target
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.951864/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.951864/full

Similar Items